Pharma channel feed

Aviv Regev re­cruits a ‘pur­ple uni­corn’ for the top post in the com­pu­ta­tion­al pil­lar she’s build­ing at Genen­tech

4 years ago
Bioregnum

Bio­Marin plots come­back year, with plans to turn around prof­its and head back to the FDA with re­ject­ed gene ther­a­py

4 years ago
Cell/Gene Tx

IRS seeks more than $7B in back tax­es and penal­ties from Am­gen for shift­ing prof­its to Puer­to Ri­co

4 years ago

One year lat­er, US Trade Rep­re­sen­ta­tive still sup­ports an IP waiv­er for Covid-19 vac­cines

4 years ago
Coronavirus
Manufacturing

Hun­dreds at NYU walk out in protest of re­ports that David Saba­ti­ni may join fac­ul­ty

4 years ago
People

With a buy­out, planned spin­out and late-stage read­outs, GSK promis­es this will be a land­mark year

4 years ago

Pub­li­cis kicks off its Health­Front me­dia event with CNN celebri­ty physi­cian and health in­dus­try changes

4 years ago
Marketing

J&J files law­suit against sev­er­al phar­ma­cies and dis­trib­u­tors over coun­ter­feit HIV med­ica­tion

4 years ago
Law

So­ci­etal CD­MO lands NCI pack­ag­ing deal for an­ti-tu­mor cap­sules fol­low­ing re­brand

4 years ago
Manufacturing

Am­gen touts its lat­est cut of longterm Repatha da­ta, still hunt­ing elu­sive bil­lions for PC­SK9 fran­chise

4 years ago

Mod­er­na CEO Stéphane Ban­cel plucks new com­mer­cial chief from Mer­ck­'s top ex­ec­u­tive team

4 years ago
People

Pfiz­er and Bio­haven bring rimegepant to Eu­rope as mi­graine war with Ab­b­Vie heats up

4 years ago

NightHawk flies in­to na­tion­al stock­pile deal with Cana­di­an gov­ern­ment for an­thrax drug

4 years ago
Manufacturing

Am­gen re-ups ESG re­port, out­lines lat­est ef­forts with fo­cus on ‘4 health­ies’

4 years ago
Marketing

Pfiz­er nabs dis­count­ed stake in Zen­tal­is af­ter AACR22 da­ta left the biotech bruised

4 years ago
Financing

No­var­tis records an­oth­er tislelizum­ab win en route to bring­ing BeiGene's PD-1 to FDA's doors

4 years ago
R&D
China

States may need to tweak gener­ic drug laws to in­crease ac­cess, re­searchers find

4 years ago

Sanofi of­floads French rights for an­tipsy­chot­ic to neigh­bor­ing phar­ma

4 years ago
Deals

NYU con­sid­ers hir­ing for­mer MIT sci­en­tist David Saba­ti­ni af­ter sex­u­al ha­rass­ment probe — re­port

4 years ago
People

Sanofi en­lists an F1 rac­ing team to help op­ti­mize its man­u­fac­tur­ing op­er­a­tions

4 years ago
Manufacturing

Vi­iV, Pfiz­er and Roche lead list for phar­ma rep­u­ta­tion ranked by pa­tient group, an­nu­al sur­vey finds

4 years ago
Marketing

Thou­sands of jobs are on the chop­ping block as No­var­tis lays out re­struc­tur­ing plans, M&A hunt for deals up to $2B

4 years ago

Mar­ket­ingRx roundup: Bio­Marin de­buts film work­shop for peo­ple with he­mo­phil­ia; J&J re­ups 'Y­ou Be­long' di­ver­si­ty push

4 years ago
Marketing

The pod peo­ple of phar­ma: Pod­cast vet­er­ans and new­bies di­al up con­ver­sa­tion­al sci­ence, en­ter­tain­ment and brand sto­ries

4 years ago
Marketing
First page Previous page 205206207208209210211 Next page Last page
A service from the Financial Times